ArticleFamilial cancer2021

FRAMe: Familial Risk Assessment of Melanoma-a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma.

Elizabeth A Holland et al.PubMed ↗Publisher ↗

No numbers read from the abstract.